Oclaro Company Profile (NASDAQ:OCLR)

Oclaro trades on the NASDAQ under the ticker symbol "OCLR."

Oclaro, Inc. (NASDAQ:OCLR) announced its quarterly earnings data on Tuesday, May, 2nd. The company reported $0.22 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.18 by $0.04. The company had revenue of $162.18 million for the quarter, compared to analysts' expectations of $160.06 million. Oclaro had a net margin of 8.83% and a return on equity of 23.12%. During the same quarter in the previous year, the company posted $0.03 EPS. View Oclaro's Earnings History.

8 equities research analysts have issued 12 month price targets for Oclaro's shares. Their forecasts range from $10.00 to $14.00. On average, they anticipate Oclaro's share price to reach $11.94 in the next twelve months. View Analyst Ratings for Oclaro.

Here are some recent quotes from research analysts about Oclaro stock:

• 1. According to Zacks Investment Research, "Oclaro, with headquarters in San Jose, California, is a tier 1 provider of high performance optical components, modules and subsystems to the telecommunications market, and is one of the largest providers to metro and long haul network applications. Oclaro, the result of the combination of Bookham, Inc. and Avanex Corporation, leverages proprietary core technologies and vertically integrated product development to provide its customers with cost-effective and innovative optical devices, modules and subsystems. Its photonic technologies also serve selected potential high growth markets, including industrial, defense, life sciences, semiconductor, and scientific, with diversification providing both significant potential revenue streams and strategic technological advantage. Oclaro is a global company, with leading chip fabrication facilities in the UK, Switzerland and Italy, and manufacturing sites in the US, Thailand and China. " (5/5/2017)
• 2. Needham & Company LLC analysts commented, " Oclaro presented a strong, confident and upbeat outlook even as Neo was lowering guidance. Oclaro noted they have seen no inventory build at ZTE and even noted ZTE was "expediting orders". Oclaro points out they expect up Q-Q in CY1Q and are the only company guiding that way among the optical companies, even taking into account the late timing of orders in China, the impact of the decline in their 40G line and the full quarter impact of the annual price reductions. Oclaro expects new tenders in China in April and pointed to the emerging DCI and pre-5G markets in China as major new opportunities. Oclaro cited exceptionally strong ACO and opportunities for growth in Data Comm as differentiating their outlook. At just 7.9x EV/E, we think the shares are an exceptional value. We reiterate our Strong Buy and $14 Target Price." (3/15/2017)
• 3. Piper Jaffray Companies analysts commented, "Oclaro reported FQ2 results in-line with the company's positive preannouncement, and provided upbeat FQ3 guidance, with revenues, gross margin and operating income all coming in ahead of consensus expectations. Following these strong results, we believe Oclaro remains one of the best positioned optical companies to see this momentum continue throughout 2017, and believe sustained strength in China and ramping US Metro and Datacom orders represent three meaningful catalysts over the next several quarters. While we took our estimates higher, we believe upside still exists to this forecast due to OCLR's CFP2-ACO leadership, as well as management's history of providing conservative guidance. Given our positive 12 month outlook, we are reiterating our Overweight rating and increasing our price target from $13 to $15." (2/1/2017)
• 4. Jefferies Group LLC analysts commented, "CAVM reported 4Q results of $226M/$0.56, topping consensus ests of $225M/$0.54. Mgmt guided 1Q to $227M/$0.56, ahead of the Street’s $225M/$0.53 ests largely due to a favorable tax benefit. 1Q GM guidance of 66.0% was ~30bps ahead of consensus and expected to expand through 2017 as QLGC inventory issues abate. Mgmt noted all legacy-CAVM greenfield products are expected to grow meaningfully in 2017, driving 2/3 of legacy-CAVM growth, with core Octeon accounting for the remaining 1/3. Net, we forecast legacy-CAVM to grow 15-20% Y/Y in 2017 while QLGC grows ~8%." (2/1/2017)

Oclaro saw a decline in short interest in May. As of May 15th, there was short interest totalling 47,831,238 shares, a decline of 7.1% from the April 28th total of 51,499,348 shares. Based on an average trading volume of 12,022,425 shares, the short-interest ratio is presently 4.0 days. Approximately 30.0% of the shares of the company are sold short.

Some companies that are related to Oclaro include Cree (CREE), Ambarella (AMBA), Brooks Automation (BRKS), Kulicke and Soffa Industries (KLIC), Veeco Instruments (VECO), Ultratech (UTEK), Nanometrics Incorporated (NANO), Photronics (PLAB), Nova Measuring Instruments (NVMI), Axcelis Technologies (ACLS), Xcerra Corp (XCRA), Cohu (COHU), Park Electrochemical Corp. (PKE), Daqo New Energy Corp (DQ), Camtek LTD. (CAMT), Amtech Systems (ASYS), eMagin (EMAN) and Enphase Energy (ENPH).

Oclaro's stock is owned by many different of retail and institutional investors. Top institutional investors include Wellington Management Group LLP (5.85%), Ameriprise Financial Inc. (4.79%), Vanguard Group Inc. (4.24%), Teachers Advisors LLC (3.08%), Whale Rock Capital Management LLC (2.80%) and TIAA CREF Investment Management LLC (2.02%). Company insiders that own Oclaro stock include Adam Carter, David Teichmann, Edward B Collins, Greg Dougherty, James Douglas Haynes, Lisa Paul, Ltd Hitachi, Marissa T Peterson, Michael H Fernicola and Thomas Gordon Beck Mason. View Institutional Ownership Trends for Oclaro.

Oclaro's stock was sold by a variety of institutional investors in the last quarter, including Driehaus Capital Management LLC, Alliancebernstein L.P., TIAA CREF Investment Management LLC, Next Century Growth Investors LLC, Garelick Capital Partners LP, Whale Rock Capital Management LLC, Nationwide Fund Advisors and Morgan Stanley. Company insiders that have sold Oclaro stock in the last year include Adam Carter, David Teichmann, Greg Dougherty, James Douglas Haynes, Lisa Paul, Michael H Fernicola and Thomas Gordon Beck Mason. View Insider Buying and Selling for Oclaro.

Oclaro's stock was purchased by a variety of institutional investors in the last quarter, including Teachers Advisors LLC, Ameriprise Financial Inc., Wellington Management Group LLP, Old Mutual Global Investors UK Ltd., Emerald Advisers Inc. PA, Vanguard Group Inc., Emerald Mutual Fund Advisers Trust and Kennedy Capital Management Inc.. Company insiders that have bought Oclaro stock in the last two years include Edward B Collins and Marissa T Peterson. View Insider Buying and Selling for Oclaro.

Shares of Oclaro can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Oclaro stock can currently be purchased for approximately $8.91.